1. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Issue 8 (August 2016) Authors: Dearnaley, David; Syndikus, Isabel; Mossop, Helen; Khoo, Vincent; Birtle, Alison; Bloomfield, David; Graham, John; Kirkbride, Peter; Logue, John; Malik, Zafar; Money-Kyrle, Julian; O'Sullivan, Joe M; Panades, Miguel; Parker, Chris; Patterson, Helen; Scrase, Christopher; Staffurth, John; Stockdale... Journal: Lancet oncology Issue: Volume 17:Issue 8(2016:Aug.) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer. (March 2018) Authors: Wilkins, Anna; Stuttle, Christine; Hassan, Shama; Blanchard, Claire; Cruickshank, Clare; Griffin, Clare; Probert, Jake; Corbishley, Catherine M; Parker, Chris; Dearnaley, David; Hall, Emma Journal: Clinical and translational radiation oncology Issue: Volume 10(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial. Issue 4 (April 2022) Authors: Dearnaley, David; Hinder, Victoria; Hijab, Adham; Horan, Gail; Srihari, Narayanan; Rich, Philip; Houston, J Graeme; Henry, Ann M; Gibbs, Stephanie; Venkitaraman, Ram; Cruickshank, Clare; Hassan, Shama; Miners, Alec; Mason, Malcolm; Pedley, Ian; Payne, Heather; Brock, Susannah; Wade, Robert; Robin... Journal: Lancet oncology Issue: Volume 23:Issue 4(2022) Page Start: 501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation. (November 2022) Authors: Murray, Julia; Cruickshank, Clare; Bird, Thomas; Bell, Philip; Braun, John; Chuter, Dave; Ferreira, Miguel Reis; Griffin, Clare; Hassan, Shama; Hujairi, Nabil; Melcher, Alan; Miles, Elizabeth; Naismith, Olivia; Panades, Miguel; Philipps, Lara; Reid, Alison; Rekowski, Jan; Sankey, Pete; Staffurth,... Journal: Clinical and translational radiation oncology Issue: Volume 37(2022) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018). (November 2020) Authors: Syndikus, Isabel; Cruickshank, Clare; Staffurth, John; Tree, Alison; Henry, Ann; Naismith, Olivia; Mayles, Helen; Snelson, Nicola; Hassan, Shama; Brown, Stephanie; Porta, Nuria; Griffin, Clare; Hall, Emma Journal: Clinical and translational radiation oncology Issue: Volume 25(2020) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗